Cytek Biosciences (CTKB) FCF Margin (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly FCF Margin came in at 11.11% in Q1 2026, down 1025.0% YoY from 1.2% in Q1 2025, and down 416.29% on a QoQ basis from 3.51% in Q4 2025.
Cytek Biosciences (CTKB) FCF Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of FCF Margin data on file, last reported at 11.11% in Q1 2026.
- Quarterly FCF Margin fell 1025.0% year-over-year to 11.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.58% (down 1547.0% YoY) and the FY2025 annual result came in at 2.39%, down 1496.0% from the prior year.
- FCF Margin retreated to 11.11% in Q1 2026, from 3.51% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 28.63% in Q3 2024 to a low of 28.19% in Q2 2022.
- A 5-year average of 1.02% and a median of 0.7% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin surged 4395 bps — and 2025, when it sank 4190 bps.
- Tracing CTKB's FCF Margin over 5 years: stood at 0.7% in 2022, then soared by 3208 bps to 21.67% in 2023, then slumped by 85 bps to 3.34% in 2024, then rose by 5 bps to 3.51% in 2025, then tumbled by 416 bps to 11.11% in 2026.
- The last three FCF Margin figures came in at 11.11% (Q1 2026), 3.51% (Q4 2025), and 13.27% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.73% |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | -1.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.76% |
| Mar 31, 2026 | -11.11% |
| Dec 31, 2025 | 3.51% |
| Sep 30, 2025 | -13.27% |
| Jun 30, 2025 | 0.66% |
| Mar 31, 2025 | -0.87% |
| Dec 31, 2024 | 3.34% |
| Sep 30, 2024 | 28.63% |
| Jun 30, 2024 | 11.05% |
| Mar 31, 2024 | 7.56% |
| Dec 31, 2023 | 21.67% |
| Sep 30, 2023 | -15.33% |
| Jun 30, 2023 | -5.52% |
| Mar 31, 2023 | 7.33% |
| Dec 31, 2022 | -0.70% |
| Sep 30, 2022 | -21.28% |
| Jun 30, 2022 | -28.19% |
| Mar 31, 2022 | -4.87% |
| Dec 31, 2021 | 10.68% |
| Sep 30, 2021 | -4.56% |